Indevus CEO to retire by Sept. 1

Indevus Pharmaceuticals Inc. said today that chief executive and chairman Glenn L. Cooper plans to retire on or before Sept. 1.

After 15 years at the helm of the Lexington company, Cooper, 55, who is also a medical doctor, said in a statement that the ‘‘time is right for me to retire.’’

Indevus said it has begun efforts to ‘‘evaluate and retain a successor chief executive officer.’’

Indevus makes such drugs as Sanctura, for overactive bladder, Vantas, for advanced prostate cancer, and Delatestryl, for male hypogonadism.
(AP)